At Arthur D. Little, we make sure you’re positioned to seize the most promising opportunities. Whether that’s by harnessing digitalization, advanced data science, AI and machine learning, or by capitalizing on developments in medical and life sciences – we’re here to help you find new growth. And with knowledge and experience across the entire public and private healthcare and life science ecosystem we’re able to identify alliances, efficiencies and dependencies. It’s helping to accelerate clinical trials, decoding the next generation of drugs, treatments and therapies and opening new possibilities in human progress.
Medical advancement converging with technological progress is transforming what’s possible in healthcare. At one end, it promises more personalized, predictive and preventative therapies – radically improving the care people receive. And at the other, it’s creating more effective, more efficient treatments and care pathways that transform how entire healthcare systems run. Organizations that can bring innovations to market more quickly and effectively will move ahead, pioneering the next generation of healthcare for the benefit of patients and society.
![Healthcare & Life Science consulting](/sites/default/files/styles/intro_and_content_s/public/2024-07/GettyImages-1187603810,P201.png,qitok=JU6YGSFo.pagespeed.ce.Ze9svPdSpS.png)
![Healthcare & Life Science consulting](/sites/default/files/styles/intro_and_content_s/public/2024-07/GettyImages-1314050988,P201.png,qitok=86Ub1ELw.pagespeed.ce.uy0R3aO1yO.png)
Our consultants don’t seek to make incremental improvements to legacy systems or simply shave costs. We blend technological know-how with strategic insight and ethical expertise to create leaps forward in performance – showing you where to focus, what to invest in and how to create new value in the sector.
![ACCELERATING CURES](/sites/default/files/styles/large_promotion_block_2_bg_xs/public/2024-07/ADL_Accelerating_cures.jpg,qitok=TaWfPQ3a.pagespeed.ce.zvnNadRTYa.jpg)
ACCELERATING CURES
Patient recruitment drives success in clinical trial execution — but is increasingly difficult. To overcome this challenge and achieve wins, clinical trial sponsors must inspire study teams to beat clinical trial patient-recruitment timeline targets.
![ADVANCING BIOTECHNOLOGY & GENOMICS IN SAUDI ARABIA](/sites/default/files/styles/large_promotion_block_2_bg_xs/public/2024-07/ADVANCING,P20BIOTECHNOLOGY,P20,P26,P20GENOMICS,P20IN,P20SAUDI,P20ARABIA.jpg,qitok=AiucL2hx.pagespeed.ce.9tqig_1Hgb.jpg)
ADVANCING BIOTECHNOLOGY & GENOMICS IN SAUDI ARABIA
Fueled by advances in emerging technologies such as precision medicine,[1] ultra-targeted therapies, “omics,”[2] and many more, the global biotechnology and genomics sector is expected to expand at a double-digit growth rate going forward. Having understood the potential of the sector, governments across the world are making concerted efforts to harness and develop their own biotechnology industries.
![CLINICAL TRIAL ACCELERATION](/sites/default/files/styles/large_promotion_block_2_bg_xs/public/2024-08/Clinical_Trial_Acceleration.jpg,qitok=h8cW4_Rr.pagespeed.ce.MwWkTM5CCA.jpg)
CLINICAL TRIAL ACCELERATION
We unlock strategies and tactics that shorten the time it takes to bring new drugs and therapies to patients. With clinical trial acceleration, we offer external insights, new ways of thinking, and make the connections needed
![CATALYZING DIGITAL HEALTH IN INDIA](/sites/default/files/styles/large_promotion_block_2_bg_xs/public/2024-07/CATALYZING,P20DIGITAL,P20HEALTH,P20IN,P20INDIA.jpg,qitok=t_wL4LIj.pagespeed.ce.A6BuqLRot9.jpg)
CATALYZING DIGITAL HEALTH IN INDIA
Digital health solutions are shaping the future of healthcare worldwide, driving numerous innovations and trends, including online pharmacies, telemonitoring, personalized medicine, and chronic disease management. The adoption of digital technologies presents opportunities for providers to expand their businesses, enhance profitability, and improve the accessibility and affordability of healthcare services.
![DATA-DRIVEN HEALTHCARE](/sites/default/files/styles/large_promotion_block_2_bg_xs/public/2024-07/DATA-DRIVEN,P20HEALTHCARE,P403x.jpg,qitok=gU3erI3N.pagespeed.ce.Eun5HYe_9R.jpg)
DATA-DRIVEN HEALTHCARE
Across the healthcare spectrum, technological innovations continue to be developed and made available to consumers at breakneck speed. Within this evolving healthcare landscape, care is becoming more personal, more patient centric, less episodic, more omnipresent, and fully embedded in the lifestyles of the population.
![THE BRAVE NEW WORLD OF SYNTHETIC BIOLOGY](/sites/default/files/styles/large_promotion_block_2_bg_xs/public/2024-07/synthetic_biology,P403x.jpg,qitok=rK6HvvJG.pagespeed.ce.HEBj3acJrL.jpg)
THE BRAVE NEW WORLD OF SYNTHETIC BIOLOGY
While the 20th century was in many ways the century of the industrialization of chemistry, the 21st century is promising a similar revolution in biology. The revolution’s foundation began with the discovery of DNA in the 1950s and expanded to core technologies that help to understand, analyze, and manipulate our genetic codes as well as the proteins and, ultimately, the cells and organs that underlay human biology and extend to the universe surrounding us.
![A BOLD VISION FOR INDIA’S DIGITAL HEALTH](/sites/default/files/styles/large_promotion_block_2_bg_xs/public/2024-07/A,P20BOLD,P20VISION,P20FOR,P20INDIAS,P20DIGITAL,P20HEALTH,P403x.jpg,qitok=vGRlWIc7.pagespeed.ce.k9NM0QlDb_.jpg)
A BOLD VISION FOR INDIA’S DIGITAL HEALTH
Following on the heels of other industries, the healthcare sector is undergoing a critical transformation to become data driven. As this revolution comes to the forefront, technology trends are emerging, but other interconnected factors related to both how data is gathered or analyzed and how stakeholders are involved can enable or hinder the change.
How we help
![Pharma, Biotech & CDMO](/sites/default/files/styles/sub_services_1st_section_image_l/public/2024-07/Pharma-Biotech-and-CDMO.jpg,qitok=Wa3TMxrG.pagespeed.ce.mmBACP9CzU.jpg)
The landscape continues to shift at pace within pharma, biotech and CDMO. Accelerated innovation and value chain disruption; increasing complexity and rising costs; disruptive digital technologies and increasing technical, clinical and regulatory risks: the need to realize objectives quicker is greater than ever. We have broad and deep expertise helping our clients navigate these and many other challenges and opportunities. Whether you’re a pharmaceutical company looking to adapt your R&D strategy and bring patient-centric products to market quicker; a biotech firm looking to position for investment and expansion; or a CDMO needing to manage the impact of emerging technologies and increasing customer expectations, we can help you realize value with a wide range of proven solutions.
Pharma & Biotech
CDMO
Indication Strategy and portfolio assessment
Helping you optimize your pipeline potential by guiding investments into the most attractive opportunities, thereby balancing risk and reward in a complex business environment.
Clinical trial design and acceleration
Developing tailored strategies and tactics that address the major causes of clinical trial delays and deliver immediate impact – saving you time, money and resources in bringing new medicines to market.
Fast-to-market and commercial excellence
Helping you develop a successful and scalable long-term strategy early on to quickly move from research to development to commercial excellence – addressing capabilities, technology, organization, processes and governance.
Digital health and patient centricity
Developing and implementing actionable strategies for digitally-enabled, patient-centric solutions – keeping you at the forefront of digital health and integrated, real-world data.
Strategy & Growth
Evaluating your organization’s capabilities, market positioning and performance to define a clear strategy and roadmap that balances short-term objectives with long-term value creation.
Strategy & Growth
Evaluating your organization’s capabilities, market positioning and performance to define a clear strategy and roadmap that balances short-term objectives with long-term value creation.
Growth strategy & partnering
Helping you identify and prioritize the most promising opportunities for growth in an increasingly competitive and consolidating market where non-traditional players are starting to operate.
New technology assessment
Assessing new technologies through the lenses of trends, customer needs and competitor offerings to identify the most promising opportunities to speed up the production of innovative and complex drugs.
Business and operating model design
Defining the best way of operating your business to give you the edge in an ever more competitive landscape – helping you focus on what to offer, how to position it and how to take it to market.
Indication Strategy and portfolio assessment
Helping you optimize your pipeline potential by guiding investments into the most attractive opportunities, thereby balancing risk and reward in a complex business environment.
Clinical trial design and acceleration
Developing tailored strategies and tactics that address the major causes of clinical trial delays and deliver immediate impact – saving you time, money and resources in bringing new medicines to market.
Fast-to-market and commercial excellence
Helping you develop a successful and scalable long-term strategy early on to quickly move from research to development to commercial excellence – addressing capabilities, technology, organization, processes and governance.
Digital health and patient centricity
Developing and implementing actionable strategies for digitally-enabled, patient-centric solutions – keeping you at the forefront of digital health and integrated, real-world data.
Strategy & Growth
Evaluating your organization’s capabilities, market positioning and performance to define a clear strategy and roadmap that balances short-term objectives with long-term value creation.
Strategy & Growth
Evaluating your organization’s capabilities, market positioning and performance to define a clear strategy and roadmap that balances short-term objectives with long-term value creation.
Growth strategy & partnering
Helping you identify and prioritize the most promising opportunities for growth in an increasingly competitive and consolidating market where non-traditional players are starting to operate.
New technology assessment
Assessing new technologies through the lenses of trends, customer needs and competitor offerings to identify the most promising opportunities to speed up the production of innovative and complex drugs.
Business and operating model design
Defining the best way of operating your business to give you the edge in an ever more competitive landscape – helping you focus on what to offer, how to position it and how to take it to market.
![Medtech & Diagnostics](/sites/default/files/styles/sub_services_1st_section_image_l/public/2024-07/Medtech-and-Diagnostics.jpg,qitok=vD78q51x.pagespeed.ce.TJkvFOyr0t.jpg)
The future will be smart, automated, inter-operable and interconnected – and it’s already disrupting the industry today. Our deep expertise in strategy, technology and convergence as well as in Medtech, Diagnostics and Early Stage Life Sciences means we are perfectly placed to help you manage the impact of new technologies, increasing innovation and changing regulation and translate it into improved business performance. From optimizing your product portfolio, processes and supply chain to converting emerging innovations into new revenue streams, we can help you formulate strategies and roadmaps for growth which match the maturity of your organization.
Strategy and business model assessment
Assessing your organization’s capabilities, market positioning and performance – and identifying opportunities for improvement and growth.
R&D and innovation strategy and excellence
Providing end-to-end support – from assessing your technological needs to implementing effective innovation strategies and optimizing productivity – to help you get the most value out of your R&D and innovation efforts.
Product development & delivery strategy
Developing the strategy you need to optimize your whole product development process – from ideation to distribution – making sure your products meet customer expectations and market demands.
Market assessment and go-to-market strategy
Providing a roadmap for successful product launches and growth – by analyzing your target market and tailoring your product launch strategy to maximize market penetration and revenue.
Growth strategy and commercial acceleration
Helping you develop a long-term strategy covering all key aspects of your business – from capabilities to processes and governance – to ensure successful and scalable growth.
Operations and supply chain excellence
Providing the backbone of efficient business performance – helping you optimize your production, logistics and distribution processes to ensure streamlined operations and a seamless supply chain.
Strategy and business model assessment
Assessing your organization’s capabilities, market positioning and performance – and identifying opportunities for improvement and growth.
R&D and innovation strategy and excellence
Providing end-to-end support – from assessing your technological needs to implementing effective innovation strategies and optimizing productivity – to help you get the most value out of your R&D and innovation efforts.
Product development & delivery strategy
Developing the strategy you need to optimize your whole product development process – from ideation to distribution – making sure your products meet customer expectations and market demands.
Market assessment and go-to-market strategy
Providing a roadmap for successful product launches and growth – by analyzing your target market and tailoring your product launch strategy to maximize market penetration and revenue.
Growth strategy and commercial acceleration
Helping you develop a long-term strategy covering all key aspects of your business – from capabilities to processes and governance – to ensure successful and scalable growth.
Operations and supply chain excellence
Providing the backbone of efficient business performance – helping you optimize your production, logistics and distribution processes to ensure streamlined operations and a seamless supply chain.
![HEALTHCARE PAYERS & PROVIDERS](/sites/default/files/styles/sub_services_1st_section_image_l/public/2024-07/HEALTHCARE-PAYERS-AND-PROVIDERS.jpg,qitok=yttos0A5.pagespeed.ce.g0CtBj664U.jpg)
As the systems that deliver care continue to evolve, we have developed significant experience in leading the transformation from ‘sick-care’ to ‘health-care’. Our expertise covers the whole value chain – including the expansion of your delivery system into ambulatory care like home-based care, telemedicine, and telehealth. With a deep understanding of the levers that improve efficiency – from optimizing care settings and clinical pathways to improving wellness – we focus on enabling value-based care and integrated delivery within public and private health systems. And with our comprehensive KPI framework we can help you evaluate and improve clinical, operational and financial efficiency across the key areas of your organization to ensure you are positioned to take advantage of the changing environment.
Healthcare strategy and transformation
Defining new operating models and care delivery designs, supporting you through any transformation to make sure it succeeds and achieves its business objectives.
Reimbursement strategy design
Developing and optimizing reimbursement models to make sure compensation for healthcare services is fair while controlling costs.
Population health management
Implementing strategies to improve health outcomes, focusing on preventative care, chronic disease management and wellness programs.
Health policy development
Helping you create and refine your health policies to align with regulatory requirements and promote effective healthcare delivery.
Quality improvement initiatives
Implementing measures to enhance the quality of healthcare services, with a focus on patient outcomes and satisfaction.
Clinical and operational efficiency optimization
Applying new strategies to boost both clinical and operational performance in order to generate better financial returns while improving clinical outcomes and patient satisfaction.
Healthcare strategy and transformation
Defining new operating models and care delivery designs, supporting you through any transformation to make sure it succeeds and achieves its business objectives.
Reimbursement strategy design
Developing and optimizing reimbursement models to make sure compensation for healthcare services is fair while controlling costs.
Population health management
Implementing strategies to improve health outcomes, focusing on preventative care, chronic disease management and wellness programs.
Health policy development
Helping you create and refine your health policies to align with regulatory requirements and promote effective healthcare delivery.
Quality improvement initiatives
Implementing measures to enhance the quality of healthcare services, with a focus on patient outcomes and satisfaction.
Clinical and operational efficiency optimization
Applying new strategies to boost both clinical and operational performance in order to generate better financial returns while improving clinical outcomes and patient satisfaction.
![Consumer Health](/sites/default/files/styles/sub_services_1st_section_image_l/public/2024-07/Consumer-Health.jpg,qitok=mO1NKXUt.pagespeed.ce.TlKkfLMl_1.jpg)
The effect of new technologies, combined with an emerging paradigm shift in healthcare and consumer attitudes, is creating a new world of preventative health. Convergence from new and emerging areas is opening opportunities for growth while increasing competition. And awareness of the importance of health and diet – among consumers as well as regulators – is pushing consumer goods companies into wellness, nutrition and dietary health. Drawing on our extensive experience in technology, healthcare and consumer goods, we can help you respond to the key trends shaping the consumer health market. We work across the entire product development cycle, sourcing the best external experts from our network where necessary to help us create value at every stage.
Strategy and business model assessment
Assessing your organization’s capabilities, market positioning and performance – and identifying opportunities for improvement and growth.
R&D and innovation strategy and excellence
Providing end-to-end support – from assessing your technological needs to implementing effective innovation strategies and optimizing productivity – to help you get the most value out of your R&D and innovation efforts.
Growth strategy and commercial acceleration
Helping you develop a long-term strategy covering all key aspects of your business – from capabilities to processes and governance – to ensure successful and scalable growth.
Market assessment and go-to-market strategy
Providing a roadmap for successful product launches and growth – by analyzing your target market and tailoring your product launch strategy to maximize market penetration and revenue.
Product development & delivery excellence
Helping you optimize and accelerate your product development process – including building capabilities to make product health claims and run clinical studies – ensuring that your products meet customer expectations and market demands.
Operations and supply chain excellence
Providing the backbone of efficient business performance – helping you optimize your production, logistics and distribution processes to ensure streamlined operations and a seamless supply chain.
Strategy and business model assessment
Assessing your organization’s capabilities, market positioning and performance – and identifying opportunities for improvement and growth.
R&D and innovation strategy and excellence
Providing end-to-end support – from assessing your technological needs to implementing effective innovation strategies and optimizing productivity – to help you get the most value out of your R&D and innovation efforts.
Growth strategy and commercial acceleration
Helping you develop a long-term strategy covering all key aspects of your business – from capabilities to processes and governance – to ensure successful and scalable growth.
Market assessment and go-to-market strategy
Providing a roadmap for successful product launches and growth – by analyzing your target market and tailoring your product launch strategy to maximize market penetration and revenue.
Product development & delivery excellence
Helping you optimize and accelerate your product development process – including building capabilities to make product health claims and run clinical studies – ensuring that your products meet customer expectations and market demands.
Operations and supply chain excellence
Providing the backbone of efficient business performance – helping you optimize your production, logistics and distribution processes to ensure streamlined operations and a seamless supply chain.
![Digital](/sites/default/files/styles/sub_services_1st_section_image_l/public/2024-07/Digital.jpg,qitok=1rYgIC0p.pagespeed.ce.vWUn90__WB.jpg)
The future of health is digital – and it is simultaneously connecting the entire healthcare ecosystem and disrupting the entire industry. It requires a fundamental rethink of the operating model of care providers. We combine deep experience in healthcare with expertise in data science, analytics, digital technology and convergence to help you capitalize on this hyper-connected environment. Whether you’re looking to improve patient engagement and care, support management, streamline processes or enhance the overall healthcare experience, we can help you create the necessary connections between different healthcare systems – and in turn open new opportunities for competitive advantage and growth. In drug discovery, we use cutting-edge AI to help at every stage – from discovery and development to delivery. Important successes include using AI to improve decision-making in R&D, clinical trials design, and regulatory processes.
Digital strategy development
Formulating comprehensive digital strategies aligned with your business objectives to make the most of new health opportunities and digital technologies.
Digital implementation and transformation
Assisting in the build-up, adoption and integration of digital technologies and strategies that drive innovation, efficiency and growth across your organization.
AI and machine learning (ML) integration
Supporting the implementation of AI and ML for predictive analytics, personalized medicine, and the optimization of various processes such as drug discovery and clinical trials.
Digital strategy development
Formulating comprehensive digital strategies aligned with your business objectives to make the most of new health opportunities and digital technologies.
Digital implementation and transformation
Assisting in the build-up, adoption and integration of digital technologies and strategies that drive innovation, efficiency and growth across your organization.
AI and machine learning (ML) integration
Supporting the implementation of AI and ML for predictive analytics, personalized medicine, and the optimization of various processes such as drug discovery and clinical trials.
![Private Equity & Transaction](/sites/default/files/styles/sub_services_1st_section_image_l/public/2024-07/Private-Equity-and-Transaction.jpg,qitok=r5I_qyJ4.pagespeed.ce.1RDixj9lHX.jpg)
Fundamental growth drivers like medical breakthroughs, an ageing population, the increasing influence of technology and the demand for preventative care have created significant investment opportunities in the healthcare and life sciences sector. But it is a complex world. Combining in-depth expertise in healthcare and life sciences, as well as across the entire investment cycle – representing both buyers and sellers – we can help you navigate the market dynamics, identify the most attractice assets and choose where best to invest.
IPO strategy & positioning
Supporting all aspects of your IPO, ensuring you have a compelling narrative that builds equity and attracts investors to achieve the best possible valuation.
Commercial, strategic and technical due diligence
Providing you with the due diligence support you need to make a go/no-go decision on a specific deal – whether commercial, strategic or technical.
M&A support
Ensuring a smooth transition post-merger by aligning the cultures, operations and structures of the two companies while identifying opportunities to streamline businesses and combine portfolios to achieve the highest possible value.
IPO strategy & positioning
Supporting all aspects of your IPO, ensuring you have a compelling narrative that builds equity and attracts investors to achieve the best possible valuation.
Commercial, strategic and technical due diligence
Providing you with the due diligence support you need to make a go/no-go decision on a specific deal – whether commercial, strategic or technical.
M&A support
Ensuring a smooth transition post-merger by aligning the cultures, operations and structures of the two companies while identifying opportunities to streamline businesses and combine portfolios to achieve the highest possible value.
MEET SOME OF OUR
TEAM MEMBERS
Our team is made up of a diverse group of individuals who bring a wealth of knowledge, experience, and expertise to the table, each and every one of our team members is committed to delivering the best possible service to our clients.
![](/sites/default/files/styles/team_block_promoted_image_l/public/team_management/Ulrica,P202.jpg,qitok=jvHKLBV7.pagespeed.ce.pz-RaCBEp2.jpg)
Dr. Ulrica Sehlstedt
Managing Partner, Board of directors, Stockholm
![](/sites/default/files/styles/team_block_promoted_image_l/public/team_management/CraigWyliev0.1.png,qitok=3Qz9xRaI.pagespeed.ce.K64LKBUS_S.png)
Craig Wylie
Managing Partner, Boston
![Ben Enejo | ADLITTLE](/sites/default/files/styles/team_block_promoted_image_l/public/team_management/BEN_ENEJO.png,qitok=KS9gm8o-.pagespeed.ce.nPYrlHkDxz.png)
Ben Enejo
Partner, Boston
![](/sites/default/files/styles/team_block_promoted_image_l/public/team_management/Ben-van-der-Schaaf_0.jpg,qitok=GpX2P6UN.pagespeed.ce.uQZ4oZsNw-.jpg)
Ben van der Schaaf
Partner, Boston
![Dr. Franziska Thomas](/sites/default/files/styles/team_block_promoted_image_l/public/team_management/franziska,P403x.jpg,qitok=l65XrDDN.pagespeed.ce.FCzRpxmrp0.jpg)
Dr. Franziska Thomas
Partner, Frankfurt
![Ryo Hanamura](/sites/default/files/styles/team_block_promoted_image_l/public/team_management/ryo-hanamura,P403x.jpg,qitok=yt35sUCp.pagespeed.ce.y9ZIaQIQwl.jpg)
Ryo Hanamura
Partner, Tokyo
![Satoshi Ohara](/sites/default/files/styles/team_block_promoted_image_l/public/team_management/Satoshi.Pharo,P403x.jpg,qitok=cKha5D5d.pagespeed.ce.22Fm_Ogb1x.jpg)
Satoshi Ohara
Partner, Tokyo
![](/sites/default/files/styles/team_block_promoted_image_l/public/team_management/Vikas,P20Kharbanda.jpg,qitok=2xw752Fm.pagespeed.ce.1sqXtXkdXG.jpg)
Vikas Kharbanda
Partner, Dubai
Browse Our
Latest Insights
Discover the latest leading-edge insights on the industries, convergence, technological development, people and our visions to create a more open world.